Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
CNY 23.78
(-0.17%)
CNY 23.78
(-0.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.29 Billion CNY | 7.0% |
| 2022 | 5.88 Billion CNY | 5.73% |
| 2021 | 5.56 Billion CNY | 24.86% |
| 2020 | 4.45 Billion CNY | 49.43% |
| 2019 | 2.98 Billion CNY | 29.03% |
| 2018 | 2.31 Billion CNY | 0.71% |
| 2017 | 2.29 Billion CNY | 10.64% |
| 2016 | 2.07 Billion CNY | 0.27% |
| 2015 | 2.07 Billion CNY | 15.53% |
| 2014 | 1.79 Billion CNY | 16.77% |
| 2013 | 1.53 Billion CNY | 7.12% |
| 2012 | 1.43 Billion CNY | 5.53% |
| 2011 | 1.35 Billion CNY | 2.84% |
| 2010 | 1.32 Billion CNY | 1.75% |
| 2009 | 1.29 Billion CNY | 105.5% |
| 2008 | 631.3 Million CNY | 22.65% |
| 2007 | 514.69 Million CNY | -12.91% |
| 2006 | 590.98 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.76 Billion CNY | 7.41% |
| 2024 Q3 | 6.52 Billion CNY | -3.18% |
| 2024 Q2 | 6.74 Billion CNY | -0.31% |
| 2023 Q4 | 6.29 Billion CNY | -1.51% |
| 2023 Q3 | 6.39 Billion CNY | -1.57% |
| 2023 Q2 | 6.49 Billion CNY | 8.57% |
| 2023 Q1 | 5.98 Billion CNY | 1.65% |
| 2023 FY | 6.29 Billion CNY | 7.0% |
| 2022 Q2 | 5.62 Billion CNY | 2.65% |
| 2022 Q4 | 5.88 Billion CNY | 7.86% |
| 2022 FY | 5.88 Billion CNY | 5.73% |
| 2022 Q3 | 5.45 Billion CNY | -2.98% |
| 2022 Q1 | 5.48 Billion CNY | -1.57% |
| 2021 Q4 | 5.56 Billion CNY | 9.35% |
| 2021 Q1 | 4.4 Billion CNY | -1.15% |
| 2021 Q2 | 5.6 Billion CNY | 27.07% |
| 2021 Q3 | 5.09 Billion CNY | -9.1% |
| 2021 FY | 5.56 Billion CNY | 24.86% |
| 2020 FY | 4.45 Billion CNY | 49.43% |
| 2020 Q4 | 4.45 Billion CNY | 3.88% |
| 2020 Q2 | 3.58 Billion CNY | 19.36% |
| 2020 Q1 | 3 Billion CNY | 0.76% |
| 2020 Q3 | 4.29 Billion CNY | 19.6% |
| 2019 Q4 | 2.98 Billion CNY | 7.97% |
| 2019 Q2 | 2.52 Billion CNY | 7.55% |
| 2019 FY | 2.98 Billion CNY | 29.03% |
| 2019 Q3 | 2.76 Billion CNY | 9.61% |
| 2019 Q1 | 2.34 Billion CNY | 1.37% |
| 2018 Q3 | 2.3 Billion CNY | -9.19% |
| 2018 Q1 | 2.43 Billion CNY | 5.89% |
| 2018 FY | 2.31 Billion CNY | 0.71% |
| 2018 Q4 | 2.31 Billion CNY | 0.45% |
| 2018 Q2 | 2.53 Billion CNY | 4.27% |
| 2017 Q3 | 2.18 Billion CNY | -2.99% |
| 2017 Q4 | 2.29 Billion CNY | 4.95% |
| 2017 FY | 2.29 Billion CNY | 10.64% |
| 2017 Q1 | 2.1 Billion CNY | 1.64% |
| 2017 Q2 | 2.25 Billion CNY | 6.91% |
| 2016 Q2 | 2.19 Billion CNY | -2.03% |
| 2016 Q1 | 2.24 Billion CNY | 8.37% |
| 2016 FY | 2.07 Billion CNY | 0.27% |
| 2016 Q3 | 2.02 Billion CNY | -8.01% |
| 2016 Q4 | 2.07 Billion CNY | 2.67% |
| 2015 Q4 | 2.07 Billion CNY | 13.75% |
| 2015 Q3 | 1.81 Billion CNY | 2.75% |
| 2015 Q2 | 1.77 Billion CNY | -2.22% |
| 2015 Q1 | 1.81 Billion CNY | 1.09% |
| 2015 FY | 2.07 Billion CNY | 15.53% |
| 2014 Q3 | 1.64 Billion CNY | 3.42% |
| 2014 Q1 | 1.59 Billion CNY | 3.85% |
| 2014 FY | 1.79 Billion CNY | 16.77% |
| 2014 Q2 | 1.59 Billion CNY | -0.04% |
| 2014 Q4 | 1.79 Billion CNY | 8.78% |
| 2013 Q4 | 1.53 Billion CNY | 5.68% |
| 2013 FY | 1.53 Billion CNY | 7.12% |
| 2013 Q3 | 1.45 Billion CNY | 2.1% |
| 2013 Q2 | 1.42 Billion CNY | -3.1% |
| 2013 Q1 | 1.46 Billion CNY | 2.45% |
| 2012 Q3 | 1.34 Billion CNY | 0.96% |
| 2012 Q2 | 1.33 Billion CNY | -1.91% |
| 2012 FY | 1.43 Billion CNY | 5.53% |
| 2012 Q4 | 1.43 Billion CNY | 6.43% |
| 2012 Q1 | 1.35 Billion CNY | 0.12% |
| 2011 Q4 | 1.35 Billion CNY | 5.72% |
| 2011 Q2 | 1.29 Billion CNY | -2.47% |
| 2011 Q3 | 1.28 Billion CNY | -1.12% |
| 2011 Q1 | 1.33 Billion CNY | 0.88% |
| 2011 FY | 1.35 Billion CNY | 2.84% |
| 2010 Q1 | 1.28 Billion CNY | -1.22% |
| 2010 Q2 | 1.24 Billion CNY | -2.98% |
| 2010 FY | 1.32 Billion CNY | 1.75% |
| 2010 Q4 | 1.32 Billion CNY | 8.34% |
| 2010 Q3 | 1.21 Billion CNY | -2.01% |
| 2009 FY | 1.29 Billion CNY | 105.5% |
| 2009 Q3 | 1.19 Billion CNY | 67.03% |
| 2009 Q2 | 715.12 Million CNY | 0.0% |
| 2009 Q4 | 1.29 Billion CNY | 8.61% |
| 2008 Q4 | 631.3 Million CNY | 0.0% |
| 2008 FY | 631.3 Million CNY | 22.65% |
| 2007 FY | 514.69 Million CNY | -12.91% |
| 2006 FY | 590.98 Million CNY | 0.0% |